Portola Pharmaceuticals, Inc. Debt to Equity Ratio 2013-2020 | PTLA
Current and historical debt to equity ratio values for Portola Pharmaceuticals, Inc. (PTLA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Portola Pharmaceuticals, Inc. debt/equity for the three months ending March 31, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-03-31 | $0.44B | $0.07B | 6.13 |
| 2019-12-31 | $0.45B | $0.13B | 3.46 |
| 2019-09-30 | $0.36B | $0.21B | 1.71 |
| 2019-06-30 | $0.37B | $0.00B | 616.00 |
| 2019-03-31 | $0.35B | $0.05B | 6.91 |
| 2018-12-31 | $0.30B | $0.09B | 3.27 |
| 2018-09-30 | $0.28B | $0.17B | 1.68 |
| 2018-06-30 | $0.29B | $0.22B | 1.33 |
| 2018-03-31 | $0.19B | $0.31B | 0.60 |
| 2017-12-31 | $0.22B | $0.35B | 0.64 |
| 2017-09-30 | $0.20B | $0.43B | 0.48 |
| 2017-06-30 | $0.19B | $0.11B | 1.70 |
| 2017-03-31 | $0.18B | $0.16B | 1.08 |
| 2016-12-31 | $0.15B | $0.19B | 0.78 |
| 2016-09-30 | $0.08B | $0.24B | 0.32 |
| 2016-06-30 | $0.08B | $0.32B | 0.26 |
| 2016-03-31 | $0.09B | $0.37B | 0.24 |
| 2015-12-31 | $0.07B | $0.43B | 0.17 |
| 2015-09-30 | $0.07B | $0.32B | 0.22 |
| 2015-06-30 | $0.07B | $0.37B | 0.20 |
| 2015-03-31 | $0.07B | $0.42B | 0.16 |
| 2014-12-31 | $0.07B | $0.35B | 0.20 |
| 2014-09-30 | $0.07B | $0.21B | 0.34 |
| 2014-06-30 | $0.05B | $0.24B | 0.22 |
| 2014-03-31 | $0.05B | $0.27B | 0.19 |
| 2013-12-31 | $0.03B | $0.30B | 0.10 |
| 2013-09-30 | $0.03B | $0.20B | 0.14 |
| 2013-06-30 | $0.03B | $0.22B | 0.14 |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
| 2012-06-30 | $0.00B | 0.00 | |
